GS vs TMO: Which Is the Better Buy?
Side-by-side comparison of The Goldman Sachs Group, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-14.
The Goldman Sachs Group, Inc. · Financial Services
$1,045.91
-45.0% upside to fair value
Grade D
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
GS trades at a lower forward P/E
(23.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GS |
TMO |
| Current Price |
$1,045.91 |
$464.61 |
| Fair Value Estimate |
$575.25 |
$498.27 |
| Upside to Fair Value |
-45.0%
|
+7.2%
|
| Market Cap |
$308.6B |
$172.7B |
| Forward P/E |
23.6x
|
25.2x
|
| EV / EBITDA |
15.9x
|
19.1x
|
| Price / Sales |
3.1x
|
3.8x
|
| Price / FCF |
-7.4x
|
25.6x
|
| Revenue Growth YoY |
-35.0%
|
+6.2%
|
| Gross Margin |
47.4%
|
39.4%
|
| Operating Margin |
17.8%
|
17.8%
|
| Return on Equity |
15.3%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
3.91%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
The Goldman Sachs Group, Inc. operates as a leading global financial services firm specializing in investment banking, securities, investment management, and consumer banking. Despite its strong brand and competitive position in financial capital markets, the company currently faces significant headwinds as evidenced by a 35% decline in revenue and a 100% drop in earnings in the most recent quart…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
GS |
TMO |
| Zone Low |
$431.44 |
$373.70 |
| Zone High |
$488.96 |
$423.53 |
| In Buy Zone? |
No
|
No
|